Some bacteria may protect against disease caused by stomach infection
Half of the world's human population is infected with the stomach bacteria called Helicobacter pylori, yet it causes disease in only about 10 percent of those infected. Other bacteria living in the stomach may be a key factor in whether or not H. pylori causes disease, according to a new study led by scientists at the University of California, Santa Cruz.
"People tend to think of the stomach as a relatively sterile environment, but it's actually populated with microbes," said Karen Ottemann, professor and chair of microbiology and environmental toxicology at UC Santa Cruz.
Researchers in Ottemann's lab were studying H. pylori infections in mice when they noticed that mice from two different suppliers had different responses to the infection, even though they were the same mouse strain and therefore genetically identical. Examining the bacteria in the stomachs of the mice (the stomach "microflora"), they found differences between the mice from different suppliers. They then used antibiotics to alter the stomach microflora in mice from a single supplier and again found changes in the response to H. pylori.
"We found that something about the preexisting microflora, before H. pylori comes into the mouse, changes the mouse's response to the infection," Ottemann said.
The findings, published in the journal Infection and Immunity, have potential implications for treating human infections. The bacteria in the stomachs of mice and humans are broadly the same—not necessarily at the species level, but the same types of bacteria are present in both, Ottemann said.
H. pylori infections can cause ulcers and stomach cancer, but most infected people don't develop any disease. Furthermore, there is evidence that H. pylori infection can protect against diseases such as esophageal cancer and asthma. For these reasons, people are only treated for the infection if they develop symptoms. With a better understanding of the effects of the stomach microflora, it might be possible to predict whether someone is likely to develop disease and should be treated for an H. pylori infection.
"It would be nice if we could predict who would get disease," Ottemann said. "The other possibility is that we might be able to identify some bacteria that could be used as a probiotic to dampen H. pylori disease."
At this point, it is not clear which bacteria are responsible for changing the response to H. pylori infection in mice. Focusing on mice from one supplier, Ottemann's team used genetic profiling techniques to identify more than 10,000 different types of bacteria present in mouse stomachs, of which about 2,000 were found in all the mice sampled.
The researchers treated some of the mice with antibiotics, which did not eliminate stomach bacteria but substantially changed the composition of the gut microflora. The altered microflora dampened the inflammatory response to H. pylori infection. When they looked for differences in the stomach microfloras of mice with and without inflammatory disease, the researchers found more than 4,000 differences—either species present in one group and not in the other, or differences in the abundances of certain species.
More work is needed to identify which differences in bacterial composition are responsible for the differences in response to H. pylori, Ottemann said. "The results do point to some potential candidates for a protective effect, such as Clostridium species, some of which are known to influence inflammation in the intestine," she said.
Journal reference:
Infection and Immunity
Provided by
University of California - Santa Cruz
-
Ulcer-causing bacteria tamed by defect in cell-targeting ability
Nov 21, 2011 |
not rated yet |
0
-
Ulcer bacteria may contribute to development of Parkinson's disease
May 22, 2011 |
not rated yet |
0
-
DNA from common stomach bacteria minimizes effects of colitis
May 05, 2011 |
not rated yet |
0
-
Common stomach bacteria may fight off inflammatory bowel disease caused by Salmonella
Nov 01, 2010 |
not rated yet |
0
-
Going from ulcers to cancer
Aug 22, 2008 |
not rated yet |
0
-
Motion perception revisited: High Phi effect challenges established motion perception assumptions
Apr 23, 2013 |
3 / 5 (2) |
2
-
Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update)
Apr 02, 2013 |
4.5 / 5 (11) |
5
-
The visual system as economist: Neural resource allocation in visual adaptation
Mar 30, 2013 |
5 / 5 (2) |
9
-
Separate lives: Neuronal and organismal lifespans decoupled
Mar 27, 2013 |
4.9 / 5 (8) |
0
-
Sizing things up: The evolutionary neurobiology of scale invariance
Feb 28, 2013 |
4.8 / 5 (10) |
14
-
Image of a Convex Lens Cut in Half Horizontally
2 hours ago
-
Ray tracing throught optical system of thick lenses
2 hours ago
-
Faraday's law on circular wire
3 hours ago
-
Specific Exergy vs Specific Flow Exergy
4 hours ago
-
The Durability of Bone: Long Falls
13 hours ago
-
Is energy convertible to matter?
14 hours ago
- More from Physics Forums - Classical Physics
More news stories
New immune system discovered
(Medical Xpress)—A research team, led by Jeremy Barr, a biology post-doctoral fellow, unveils a new immune system that protects humans and animals from infection.
Immunology
May 20, 2013 |
4.8 / 5 (22) |
8
|
Vitamin D could provide new and effective treatments for asthma
(Medical Xpress)—Scientists at King's College London have discovered that Vitamin D has the potential to significantly reduce the symptoms of asthma. The study, led by Professor Catherine Hawrylowicz from ...
Immunology
May 20, 2013 |
5 / 5 (1) |
0
|
Immune protein could stop diabetes in its tracks
Melbourne researchers have identified an immune protein that has the potential to stop or reverse the development of type 1 diabetes in its early stages, before insulin-producing cells have been destroyed.
Immunology
May 20, 2013 |
5 / 5 (5) |
0
|
Stem-cell-based strategy boosts immune system in mice
Raising hopes for cell-based therapies, UC San Francisco researchers have created the first functioning human thymus tissue from embryonic stem cells in the laboratory. The researchers showed that, in mice, ...
Immunology
May 16, 2013 |
4.8 / 5 (5) |
0
|
Resistance to visceral leishmaniasis: New mechanisms involved
Researchers from CNRS, Université Toulouse III - Paul Sabatier and IRD have elucidated new molecular mechanisms involved in resistance to visceral leishmaniasis, a serious parasitic infection. They have shown that dectin-1 ...
Immunology
May 16, 2013 |
not rated yet |
0
Study finds new pneumococcal vaccine appears to be as safe as previously used vaccine
The new 13-valent pneumococcal conjugate vaccine (PCV13) appears to be as safe as the previous version used prior to 2010, the 7-valent pneumococcal conjugate vaccine (PCV7), according to a Kaiser Permanente study published ...
Addiction to unhealthy foods could help explain the global obesity epidemic
Research presented today shows that high-fructose corn syrup can cause behavioural reactions in rats similar to those produced by drugs of abuse such as cocaine. These results, presented by addiction expert Francesco Leri, ...
Study says empathy plays a key role in moral judgments
Is it permissible to harm one to save many? Those who tend to say "yes" when faced with this classic dilemma are likely to be deficient in a specific kind of empathy, according to a report published in the scientific journal ...
A molecular explanation for age-related fertility decline in women
(Medical Xpress)—Scientists supported by the National Institutes of Health have a new theory as to why a woman's fertility declines after her mid-30s. They also suggest an approach that might help slow ...
Phthalates: Study links chemicals widely found in plastics, processed food to elevated blood pressure in children, teens
Plastic additives known as phthalates (pronounced THAL-ates) are odorless, colorless and just about everywhere: They turn up in flooring, plastic cups, beach balls, plastic wrap, intravenous tubing and—according to the ...
Medical researchers discover new ways to target, develop and design drugs to prevent and treat viral infection
Researchers at the University of Alberta have discovered a new drug target, developed a new drug and identified a new way to design drugs—all of which could be a winning combination in the battle against viruses.